P Burtin

5.2k total citations · 2 hit papers
40 papers, 4.0k citations indexed

About

P Burtin is a scholar working on Dermatology, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, P Burtin has authored 40 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Dermatology, 8 papers in Pediatrics, Perinatology and Child Health and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in P Burtin's work include Allergic Rhinitis and Sensitization (7 papers), Dermatology and Skin Diseases (7 papers) and Anesthesia and Sedative Agents (6 papers). P Burtin is often cited by papers focused on Allergic Rhinitis and Sensitization (7 papers), Dermatology and Skin Diseases (7 papers) and Anesthesia and Sedative Agents (6 papers). P Burtin collaborates with scholars based in France, Switzerland and United Kingdom. P Burtin's co-authors include Reinhard Hohlfeld, Ernst‐Wilhelm Radue, Peter A. Calabresi, Ludwig Kappos, Krzysztof Selmaj, Chris H. Polman, Lixin Zhang-Auberson, Catherine Agoropoulou, Paul O’Connor and Małgorzata Leyk and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nature Reviews Drug Discovery.

In The Last Decade

P Burtin

35 papers receiving 3.8k citations

Hit Papers

A Placebo-Controlled Trial of Oral Fingolimod in Relapsin... 2010 2026 2015 2020 2010 2010 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
    2010 2.0k citations Ludwig Kappos, Ernst‐Wilhelm Radue et al. New England Journal of Medicine profile →
  2. Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
    2010 1.0k citations Volker Brinkmann, Andreas Billich et al. Nature Reviews Drug Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Burtin France 16 1.8k 1.6k 638 525 443 40 4.0k
Robert Schmouder United States 32 2.2k 1.3× 729 0.5× 765 1.2× 138 0.3× 520 1.2× 93 5.4k
Stefania Rossi Italy 34 1.1k 0.6× 861 0.5× 540 0.8× 288 0.5× 630 1.4× 123 3.7k
Jan Aten Netherlands 42 2.4k 1.4× 539 0.3× 990 1.6× 174 0.3× 729 1.6× 104 5.3k
Paolo Gallo Italy 23 1.4k 0.8× 1.9k 1.2× 491 0.8× 637 1.2× 565 1.3× 106 3.7k
Katherine Dawson United States 18 903 0.5× 2.3k 1.4× 637 1.0× 762 1.5× 806 1.8× 32 3.5k
Yuan-Tsong Chen Taiwan 33 1.1k 0.6× 1.0k 0.6× 576 0.9× 134 0.3× 320 0.7× 75 5.2k
Junichi Masuda Japan 38 1.1k 0.6× 197 0.1× 731 1.1× 484 0.9× 339 0.8× 161 4.8k
Kin‐Mang Lau Hong Kong 34 1.6k 0.9× 399 0.2× 359 0.6× 103 0.2× 545 1.2× 82 3.9k
Leandro Cerchietti United States 42 2.9k 1.7× 1.0k 0.7× 992 1.6× 131 0.2× 1.6k 3.7× 132 5.4k
Yuan-Tsong Chen Taiwan 30 1.1k 0.6× 689 0.4× 732 1.1× 118 0.2× 288 0.7× 51 5.2k

Countries citing papers authored by P Burtin

Since Specialization
Citations

This map shows the geographic impact of P Burtin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Burtin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Burtin more than expected).

Fields of papers citing papers by P Burtin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Burtin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Burtin. The network helps show where P Burtin may publish in the future.

Co-authorship network of co-authors of P Burtin

This figure shows the co-authorship network connecting the top 25 collaborators of P Burtin. A scholar is included among the top collaborators of P Burtin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Burtin. P Burtin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kappos, Ludwig, Ernst‐Wilhelm Radue, Paul O’Connor, et al.. (2010). A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis. New England Journal of Medicine. 362(5). 387–401. 1960 indexed citations breakdown →
2.
Brinkmann, Volker, Andreas Billich, Thomas Baumruker, et al.. (2010). Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nature Reviews Drug Discovery. 9(11). 883–897. 1015 indexed citations breakdown →
3.
Staab, Doris, David M. Pariser, Alice B. Gottlieb, et al.. (2005). Low Systemic Absorption and Good Tolerability of Pimecrolimus, Administered as 1% Cream (Elidel®) in Infants with Atopic Dermatitis – A Multicenter, 3‐Week, Open‐Label Study. Pediatric Dermatology. 22(5). 465–471. 37 indexed citations
4.
Leusse, A de, B. Landi, Joël Edery, et al.. (2005). Video Capsule Endoscopy for Investigation of Obscure Gastrointestinal Bleeding: Feasibility, Results, and Interobserver Agreement. Endoscopy. 37(7). 617–621. 49 indexed citations
5.
Scott, Graham, Stuart Osborne, Gérard Greig, et al.. (2003). Pharmacokinetics of Pimecrolimus, a Novel Nonsteroid Anti-Inflammatory Drug, After Single and Multiple Oral Administration. Clinical Pharmacokinetics. 42(14). 1305–1314. 6 indexed citations
6.
Kovarik, John M. & P Burtin. (2003). Immunosuppressants in advanced clinical development for organ transplantation and selected autoimmune diseases. Expert Opinion on Emerging Drugs. 8(1). 47–62. 48 indexed citations
7.
8.
Harper, John, et al.. (2001). First experience of topical SDZ ASM 981 in children with atopic dermatitis. British Journal of Dermatology. 144(4). 781–787. 116 indexed citations
9.
Berkovitch, Matitiahu, T. Bistritzer, M Aladjem, et al.. (1998). Clinical Relevance of Therapeutic Drug Monitoring of Digoxin and Gentamicin in the Saliva of Children. Therapeutic Drug Monitoring. 20(3). 253–256. 8 indexed citations
10.
Kaassis, Mehdi, et al.. (1997). A Case of Colonic Pseudolipomatosis: A Rare Complication of Colonoscopy?. Endoscopy. 29(4). 325–327. 10 indexed citations
11.
Burtin, P & Évelyne Jacqz-Aigrain. (1996). Intérêt de l'approche de population pour l'étude de la variabilité pharmacocinétique en pédiatrie. Archives de Pédiatrie. 3. S239–S241. 2 indexed citations
12.
Jacqz-Aigrain, Évelyne & P Burtin. (1996). Clinical Pharmacokinetics of Sedatives in Neonates. Clinical Pharmacokinetics. 31(6). 423–443. 59 indexed citations
13.
Jacqz-Aigrain, Évelyne & P Burtin. (1996). Pharmacologie des catécholamines en pédiatrie. Réanimation Urgences. 5(4). 481–492. 1 indexed citations
14.
Jacqz-Aigrain, Évelyne, P Burtin, Inês Azevedo, et al.. (1995). Les corticoïdes: pharmacologie et indications des cures courtes en pédiatrie. Archives de Pédiatrie. 2(4). 353–364. 4 indexed citations
15.
Burtin, P, Évelyne Jacqz-Aigrain, Pascal Girard, et al.. (1994). Population pharmacokinetics of midazolam in neonates. Clinical Pharmacology & Therapeutics. 56(6). 615–625. 113 indexed citations
16.
Burtin, P. (1991). Hypotension with midazolam and fentanyl in the newborn letter. The Lancet. 337. 1545–1546. 3 indexed citations
17.
18.
Potet, F, et al.. (1969). Maladie de Waldenström et amylose. (A propos d'une observation anatomo-clinique). 45(12).
19.
20.
Burtin, P. (1954). [Immunochemical diffusion methods in a gelatinous medium].. PubMed. 4(8-9). 641–50. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert Schmouder Breakdown of academic impact, for papers by Stefania Rossi Breakdown of academic impact, for papers by Jan Aten Breakdown of academic impact, for papers by Paolo Gallo Breakdown of academic impact, for papers by Katherine Dawson Breakdown of academic impact, for papers by Yuan-Tsong Chen Breakdown of academic impact, for papers by Junichi Masuda Breakdown of academic impact, for papers by Kin‐Mang Lau Breakdown of academic impact, for papers by Leandro Cerchietti Breakdown of academic impact, for papers by Yuan-Tsong Chen
Rankless by CCL
2026